← Leaderboards
Dov Kadmon
Baylor College Of Medicine
$403,249
Attributed
$403,249
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $11.6K · FY2007–10$20K$15K$10K$5K$0
'07
'08
'09
'10
Funding mix
By agency
NIH$403,249 · 8
By mechanism
M01$228,577 · 5
P50$174,672 · 3
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Dolores Jean Lamb$15,622,235
- Michael M. Ittmann$8,988,557
- Arun Sreekumar$9,871,133
- Kevin M Slawin$3,205,103
- David R Rowley$11,107,276
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchProstate NeoplasmsHuman SubjectProstate Specific AntigenHuman Therapy EvaluationClinical Trial Phase IAthymic MouseVitamin TherapyDrug Screening /EvaluationRetinoidsNonhuman Therapy EvaluationVitamin MetabolismTissue /Cell CultureInterferon AlphaBenign Prostate HyperplasiaFenretinideNeoplasm /Cancer ChemotherapyVitamin DCombination ChemotherapyCellsCell PhysiologyDose-LimitingCell Differentiation ProcessApoptotic
Grant awards (15)
CLINICAL TRIAL: A PHASE I STUDY OF IN-SITU, NEOADJUVANT, PRE-RADICAL PROSTATECTO$9,920
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: A PHASE I STUDY OF IN-SITU, NEOADJUVANT, PRE-RADICAL PROSTATECTO$9,776
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A PHASE I STUDY OF IN-SITU, NEOADJUVANT, PRE-RADICAL PROSTATECTO$11,600
M01 · FY2008 · RR · contact PI
A PHASE I STUDY OF IN-SITU, NEOADJUVANT, PRE-RADICAL PROSTATECTOMY RTVP-1 GEN$5,565
M01 · FY2007 · RR · contact PI
CAREER DEVELOPMENT PROGRAM$0
P50 · FY2002 · CA
DEVELOPMENT OF RTVP-1 GENE THERAPY FOR PROSTATE CANCER$0
P50 · FY2002 · CA
NEOADJUVANT PRE RADICAL PROSTATECTOMY GENE THERAPY$155,764
M01 · FY2001 · RR
BIOLOGICAL THERAPY FOR PROSTATE CANCER$0
P50 · FY2001 · CA
BIOLOGICAL THERAPY FOR PROSTATE CANCER$0
P50 · FY2001 · CA
BIOLOGICAL THERAPY FOR PROSTATE CANCER$174,672
P50 · FY2000 · CA
NEOADJUVANT PRE RADICAL PROSTATECTOMY GENE THERAPY$35,952
M01 · FY2000 · RR
BIOLOGICAL THERAPY FOR PROSTATE CANCER$0
P50 · FY2000 · CA
BIOLOGICAL THERAPY FOR PROSTATE CANCER$0
P50 · FY2000 · CA
BIOLOGICAL THERAPY FOR PROSTATE CANCER$0
P50 · FY2000 · CA
BIOLOGICAL THERAPY FOR PROSTATE CANCER$0
P50 · FY2000 · CA